Live Breaking News & Updates on Strategic Inputs

Stay updated with breaking news from Strategic inputs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

​​Financing Primary Care​

​​Session six of the PHC interest group’s ten-part seminar series “Primary Health Care: The heart of every health system” that is running once a month throughout the 2022/23 academic year.   ​The seminar series provides an overview of the key functions and features of PHC; its potential in achieving universal health coverage and its role in global health. Seminars are led by speakers working in a range of settings.  ....

United Kingdom , Luke Allen , Martin Roland , Adriano Massuda , Luisa Pettigrew , Josephine Exley , Kara Hanson , Brazilian Ministry Of Health , Professor Of Health Services Research , Professor Of Health System Economics , Cambridge Centre For Health Services Research , University Of Cambridge , Harvard School Of Public Health , Pan American Health Organization , Health Care , Vargas School Of Business Administration , Health System , Lancet Global Health Commission , Financing Primary Health , Emeritus Professor , Health Services Research , Cambridge Centre , Health Services , Vargas School , Deputy Secretary , Strategic Inputs ,

How to Build Trusted Priority-Setting Systems to Increase Value for Money in Health Care Decisions

While HTA systems in different countries are influenced by differences in local culture, history, politics and healthcare financing mechanisms, there are key elements common across countries that determine the success of an HTA system. To discuss these tried and tested global practices, the government of India hosted an international symposium in New Delhi in collaboration with the International Decision Support Initiative (iDSI). HTA specialists from Australia, Colombia, India, Thailand, and the UK participated in the event along with senior Indian policymakers and experts from the World Health Organization. About 500 people joined in person or virtually to learn how HTA is bridging the gap between research evidence and real-world policy. In this blog, we explore four key actions the speakers identified as central to successful HTA systems across multiple countries. ....

United Kingdom , New Delhi , Centers For Medicare Medicaid Services , Health Technology Assessment Board , World Health Organization , Ministry Of Health , National Advisory Body , Advisory Committee , Health Technology Assessment , Secretariat Of Science Technology , Health Services , National Institute For Health , National Health Systems Cost Database , Canadian Agency For Drugs , International Decision Support Initiative , Technologies In Health , Institute Of Health Technology Assessment , World Health , National Institute , Care Excellence , Pharmaceutical Benefits Advisory Committee , Science Technology , Strategic Inputs , Canadian Agency , Technology Assessment , India Manual ,

INSIGHT-The man behind Brazil's search for miracle COVID-19 cures


11 Min Read
RIO DE JANEIRO, May 14 (Reuters) - Brazilian President Jair Bolsonaro, addressing the nation last month in a social media video, touted the latest in a string of unconventional drugs he says can ease the country’s COVID-19 crisis.
Bolsonaro - a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine - said this new drug, Proxalutamide, would “soon be available to all Brazil.” He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise.
Angotti, an eye doctor with no epidemiological experience, cited a domestic Proxalutamide study showing a 92% decrease in mortality risk among hospitalized COVID-19 patients. It was a dramatic claim amid a global struggle to find effective treatments. He said he aimed to “get it to the Brazilian population as soon as possible.” ....

Sao Paulo , Estado De Pernambuco , United States , Brian Thevenot , Fiocruz Amaz , Adriano Massuda , Alexandre Cavalcanti , Ricardo Zimerman , Gabriel Stargardter , Carlos Wambier , Felipe Naveca , Jair Bolsonaro , Thomson Reuters Trust Principles , Sao Paulo Hcor Research Institute , Health Ministry , University Of Pernambuco , Health Ministry Science , Brown University , Brazil Federal Council Of Medicine , President Jair Bolsonaro , Helio Angotti , Research Institute , New England Journal , Brazilian Proxalutamide , Strategic Inputs , Like Bolsonaro ,

The man behind Brazil's search for miracle COVID-19 cures


11 Min Read
RIO DE JANEIRO (Reuters) -Brazilian President Jair Bolsonaro, addressing the nation last month in a social media video, touted the latest in a string of unconventional drugs he says can ease the country’s COVID-19 crisis.
Helio Angotti Neto, chief of the Health Ministry s Science, Technology, Innovation and Strategic Inputs department attends a news conference in Brasilia, Brazil June 27, 2020. Carolina Antunes/Brazilian Presidency via REUTERS
Bolsonaro - a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine - said this new drug, Proxalutamide, would “soon be available to all Brazil.” He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise. ....

Sao Paulo , Estado De Pernambuco , United States , Brian Thevenot , Fiocruz Amaz , Adriano Massuda , Alexandre Cavalcanti , Ricardo Zimerman , Gabriel Stargardter , Carlos Wambier , Felipe Naveca , Jair Bolsonaro , Thomson Reuters Trust Principles , Sao Paulo Hcor Research Institute , Health Ministry , University Of Pernambuco , Health Ministry Science , Brown University , Brazil Federal Council Of Medicine , President Jair Bolsonaro , Helio Angotti , Research Institute , New England Journal , Brazilian Proxalutamide , Strategic Inputs , Like Bolsonaro ,